These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39050052)

  • 1. Combination of Plasma Rich in Growth Factors With Topical 4% Hydroquinone Compared With Topical 4% Hydroquinone Alone in the Treatment of Dermal Type of Melasma: A Single-Blinded Randomized Split-Face Study.
    Amiri R; Karimi Maskooni M; Farsinejad A; Karvar M; Khalili M; Aflatoonian M
    Indian Dermatol Online J; 2024; 15(4):593-598. PubMed ID: 39050052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
    Tekam PS; Belgaumkar VA
    Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
    Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
    J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
    Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
    Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Hydroquinone and Fractional CO
    Nourmohammadi Abadchi S; Fatemi Naeini F; Beheshtian E
    Indian J Dermatol; 2019; 64(2):129-135. PubMed ID: 30983609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Therapeutic Efficacy and Safety of Tranexamic Acid Local Infiltration in Combination with Topical 4% Hydroquinone Cream Compared to Topical 4% Hydroquinone Cream Alone in Patients with Melasma: A Split-Face Study.
    Tehranchinia Z; Saghi B; Rahimi H
    Dermatol Res Pract; 2018; 2018():8350317. PubMed ID: 30079087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Platelet-Rich Plasma Therapy as an Adjuvant in Treatment of Melasma.
    Bikash C; Sarkar R; Relhan V; Singh S
    Dermatol Surg; 2022 Apr; 48(4):429-434. PubMed ID: 35143442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of intradermal injected tranexamic acid vs hydroquinone cream in the treatment of melasma.
    Pazyar N; Yaghoobi R; Zeynalie M; Vala S
    Clin Cosmet Investig Dermatol; 2019; 12():115-122. PubMed ID: 30858717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential therapy with topical clobetasol for 14 days followed by hydroquinone versus hydroquinone alone in facial melasma treatment: a randomized, double-blind, controlled clinical trial.
    de Amorim RP; Barbosa MMC; Cassiano DP; Esposito ACC; Dias MO; de Abreu AFT; Bagatin E; Miot HA
    Int J Dermatol; 2024 Sep; 63(9):1221-1226. PubMed ID: 38411257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal Injection of 100mg Tranexamic Acid Versus Topical 4% Hydroquinone for the Treatment of Melasma: A Randomized, Controlled Trial.
    Pazyar N; Dezfuly MB; Hadibarhaghtalab M; Parvar SY; Molavi SN; Mapar MA; Zeinali M
    J Clin Aesthet Dermatol; 2023 Jan; 16(1):35-40. PubMed ID: 36743976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Split-Face Comparison of the Combined Er-YAG Laser and Hydroquinone 4% With Hydroquinone 4% Alone in the Treatment of Melasma in Iranian Patients: A Prospective, Interventional Case Study.
    Namazi N; Hesami A; Ketabi Y
    J Lasers Med Sci; 2020; 11(1):70-73. PubMed ID: 32099630
    [No Abstract]   [Full Text] [Related]  

  • 13. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma.
    Badawi AM; Osman MA
    Clin Cosmet Investig Dermatol; 2018; 11():13-20. PubMed ID: 29379308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial.
    Liang S; Shang S; Zhang W; Tan A; Zhou B; Mei X; Li L
    Front Med (Lausanne); 2023; 10():1132823. PubMed ID: 37056729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
    Saki N; Darayesh M; Heiran A
    J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products for Melasma.
    Kaufman BP; Alexis AF
    J Drugs Dermatol; 2020 Sep; 19(9):822-827. PubMed ID: 33026755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 755-nm alexandrite picosecond laser in melasma management.
    Pulumati A; Jaalouk D; Algarin YA; Nouri K
    Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
    Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
    Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma.
    Janney MS; Subramaniyan R; Dabas R; Lal S; Das NM; Godara SK
    J Cutan Aesthet Surg; 2019; 12(1):63-67. PubMed ID: 31057273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.